Jubilant Ingrevia Limited (JUBLINGREA) Share Price
NSE · Basic Materials · Specialty Chemicals · ISIN INE0BY001018
Key metrics
- Market Cap
- ₹10,789 Cr
- P/E Ratio
- 34.85
- EPS
- 19.63
- Book Value
- 194.72
- P/B Ratio
- 3.55
- ROE
- 8.89%
- ROCE
- 10.55%
- Debt / Equity
- 0.25
- Net Margin
- 6.4%
- Revenue Growth
- 5.36%
- Profit Growth
- 10.64%
- Dividend Yield
- 0.73%
- 52W High
- ₹795.00
- 52W Low
- ₹537.30
- Market Cap Band
- mid cap
- Face Value
- 1
Ratios computed from the annual results period ending 2026-03-31.
About Jubilant Ingrevia Limited
Jubilant Ingrevia Limited engages in life science products and solutions in India, the United States, Europe, China and internationally. It operates in three segments, Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions. The Nutrition & Health Solutions segment provides nutrition and health ingredients; and animal and human nutrition health solutions. The Chemical intermediates segment offers acetyls and specialty ethanol, such as acetic anhydride, bio acetic acid, bio-acetaldehyde, ethyl acetate, propionic anhydride, and formaldehyde. The company also provides vitamins, mineral premixes, stress regulator, amino acid, herbal choline, herbal non-antibiotic growth promoter and egg quality enhancer, toxin binder, acidifiers, and enzymes and emulsifiers. It serves pharmaceutical, nutrition, agrochemical, personal care, semiconductor, and industrial sectors. The company was formerly known as Jubilant LSI Limited and changed its name to Jubilant Ingrevia Limited in October 2020. Jubilant Ingrevia Limited was incorporated in 2019 and is headquartered in Noida, India.
- Headquarters
- Noida, India
- Employees
- 2,185
- Promoter Holding
- 50.89%
The full Jubilant Ingrevia Limited analysis
Create a free account to open the complete JUBLINGREA deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.